Policy swings have made it a slippery year for pharma ...
Fosun is joining the fray through its subsidiary Yao Pharma, which has granted Pfizer an exclusive worldwide license to ...
The Chief Executive Officer of Aga Khan University Hospital, Nairobi, Kenya, Rashid Khalani, has decried the low representation of Africans in global clinical trials for new drugs, despite the ...
Zacks Investment Research on MSN
Here's why AstraZeneca (AZN) is a strong growth stock
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...
Compare Oxford's #1 THE rank with Imperial's #2 QS rank in the 2026 global rankings of the UK's elite. Examine Oxford, ...
Explore Pfizer Inc.’s 2025-2026 outlook: challenges, flat revenues, patent risks, and potential from the Metsera deal. Click ...
Malawi breaking news publishing 24 hours a day news about Malawi, Malawi Business, Malawi Tourism, Malawi Politics, Malawi News ...
We found that one-third of pharmaceutical companies proactively released the launch price of their medications between 2022 and 2024, and another third released them reactively. Smaller public ...
Discusses Oncology Pipeline Advances and Phase III Clinical Updates at Science and Technology Day December 15, ...
Prominently featured in The Inner Circle, Melvin Colón is recognized as a Pinnacle Professional Member Inner Circle of Excellence for his contributions to MCD CONSULTING SERVICES INC. Melvin Colón has ...
There’s a reason dengue infections are also called “breakbone fever.” Along with a mild fever, symptoms of the mosquito-borne ...
Although development of a jab for the H5N1 strain of avian flu is well under way, other strains are receiving less attention ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results